Shelly Guest Cermak

Array ( [id] => 3033946 [patent_doc_number] => 05372808 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-13 [patent_title] => 'Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect' [patent_app_type] => 1 [patent_app_number] => 7/868916 [patent_app_country] => US [patent_app_date] => 1992-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7161 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/372/05372808.pdf [firstpage_image] =>[orig_patent_app_number] => 868916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3475055 [patent_doc_number] => 05428010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-27 [patent_title] => 'Biologically active B-chain homodimers' [patent_app_type] => 1 [patent_app_number] => 7/852905 [patent_app_country] => US [patent_app_date] => 1992-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15313 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/428/05428010.pdf [firstpage_image] =>[orig_patent_app_number] => 852905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2934529 [patent_doc_number] => 05189144 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-23 [patent_title] => 'Human calpastatin-like polypeptide' [patent_app_type] => 1 [patent_app_number] => 7/852343 [patent_app_country] => US [patent_app_date] => 1992-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 4 [patent_no_of_words] => 4912 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/189/05189144.pdf [firstpage_image] =>[orig_patent_app_number] => 852343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3029915 [patent_doc_number] => 05349055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-20 [patent_title] => 'Nerve growth factor having altered receptor binding specificities' [patent_app_type] => 1 [patent_app_number] => 7/847369 [patent_app_country] => US [patent_app_date] => 1992-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 23 [patent_no_of_words] => 11222 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/349/05349055.pdf [firstpage_image] =>[orig_patent_app_number] => 847369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2934126 [patent_doc_number] => 05219989 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Bifunctional protein for the isolation of capped mRNA' [patent_app_type] => 1 [patent_app_number] => 7/840565 [patent_app_country] => US [patent_app_date] => 1992-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4016 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219989.pdf [firstpage_image] =>[orig_patent_app_number] => 840565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2934231 [patent_doc_number] => 05219994 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-15 [patent_title] => 'Inhibitor of tissue factor activity' [patent_app_type] => 1 [patent_app_number] => 7/830462 [patent_app_country] => US [patent_app_date] => 1992-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 6962 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/219/05219994.pdf [firstpage_image] =>[orig_patent_app_number] => 830462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3085770 [patent_doc_number] => 05280109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-18 [patent_title] => 'Isolated, large latent complexes of TGF-.beta.2 and TGF-.beta.3, and new binding protein for latent form TGF-.beta.1, TGF-.beta.2 and TGF-.beta.3 LTBP-2' [patent_app_type] => 1 [patent_app_number] => 7/826577 [patent_app_country] => US [patent_app_date] => 1992-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 18 [patent_no_of_words] => 4192 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/280/05280109.pdf [firstpage_image] =>[orig_patent_app_number] => 826577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3038563 [patent_doc_number] => 05376567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-27 [patent_title] => 'Expression of interferon genes in Chinese hamster ovary cells' [patent_app_type] => 1 [patent_app_number] => 7/819626 [patent_app_country] => US [patent_app_date] => 1992-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 24 [patent_no_of_words] => 13686 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/376/05376567.pdf [firstpage_image] =>[orig_patent_app_number] => 819626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3058874 [patent_doc_number] => 05310550 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-10 [patent_title] => 'Method of treating thrombocytopenia using human BCDF in combination with IL-3' [patent_app_type] => 1 [patent_app_number] => 7/818527 [patent_app_country] => US [patent_app_date] => 1992-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4048 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/310/05310550.pdf [firstpage_image] =>[orig_patent_app_number] => 818527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3087089 [patent_doc_number] => 05278145 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-11 [patent_title] => 'Method for protecting bone marrow against chemotherapeutic drugs using transforming growth factor beta 1' [patent_app_type] => 1 [patent_app_number] => 7/815608 [patent_app_country] => US [patent_app_date] => 1992-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5224 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/278/05278145.pdf [firstpage_image] =>[orig_patent_app_number] => 815608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2929695 [patent_doc_number] => 05187263 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-16 [patent_title] => 'Expression of biologically active PDGE analogs in eucaryotic cells' [patent_app_type] => 1 [patent_app_number] => 7/818397 [patent_app_country] => US [patent_app_date] => 1992-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15244 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/187/05187263.pdf [firstpage_image] =>[orig_patent_app_number] => 818397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3029829 [patent_doc_number] => 05342831 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-30 [patent_title] => 'Epitheliocyte growth accelerator' [patent_app_type] => 1 [patent_app_number] => 7/815333 [patent_app_country] => US [patent_app_date] => 1991-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 5328 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/342/05342831.pdf [firstpage_image] =>[orig_patent_app_number] => 815333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2999603 [patent_doc_number] => 05359047 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-25 [patent_title] => 'Nucleic acids encoding DNA structure-specific recognition protein and uses therefor' [patent_app_type] => 1 [patent_app_number] => 7/814964 [patent_app_country] => US [patent_app_date] => 1991-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 29012 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/359/05359047.pdf [firstpage_image] =>[orig_patent_app_number] => 814964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2923834 [patent_doc_number] => 05200508 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-06 [patent_title] => 'Cell surface antigen that binds with L6 monoclonal antibody' [patent_app_type] => 1 [patent_app_number] => 7/807787 [patent_app_country] => US [patent_app_date] => 1991-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7456 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/200/05200508.pdf [firstpage_image] =>[orig_patent_app_number] => 807787 [rel_patent_id] =>[rel_patent_doc_number] =>)